NIH-developed HIV antibodies protect animals in proof-of-concept study
Findings support the HIV fusion peptide as a promising preventive vaccine target.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | National Institutes of Health (NIH) | Study | Vaccines | Veterinary Vaccinations